(S (NP (NNP Drug-target) (NN interaction) (PRN (-LRB- -LRB-) (NP (NNP DTI)) (-RRB- -RRB-)) (NN prediction)) (VP (VBZ plays) (NP (DT a) (ADJP (RB very) (JJ important)) (NN role)) (PP (IN in) (NP (NP (NN drug) (NN development)) (CC and) (NP (NN drug) (NN discovery))))) (. .))
(S (PP (IN In) (NP (JJ particular))) (, ,) (NP (NN machine) (NN learning) (NNS approaches)) (VP (VBP have) (VP (VBN attracted) (NP (VBG increasing) (NNS attentions)) (ADVP (RB recently)))) (. .))
(S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (DT the) (VBN known) (NN drug-target) (NNS interactions))))) (, ,) (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (NN machine) (VBG learning) (NNS methods)))) (VP (VBP require) (NP (NP (JJ extra) (JJ characteristic) (NN information)) (PP (JJ such) (IN as) (NP (NP (NN chemical) (NNS structures)) (, ,) (NP (JJ genome) (NNS sequences)) (, ,) (NP (VBG binding) (NNS types)) (CC and) (ADVP (RB so) (IN on)))))) (. .))
(S (SBAR (WHADVP (WRB Whenever)) (S (NP (JJ such) (NN information)) (VP (VBZ is) (RB not) (ADJP (JJ available))))) (, ,) (NP (PRP they)) (VP (MD may) (VP (VB perform) (ADVP (JJ poor)))) (. .))
(S (ADVP (RB Very) (RB recently)) (, ,) (NP (DT the) (JJ similarity-based) (NN link) (NN prediction) (NNS methods)) (VP (VBD were) (VP (VBN extended) (PP (TO to) (NP (NP (VB bipartite) (NNS networks)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB be) (VP (VBN applied) (S (VP (TO to) (VP (VB solve) (NP (DT the) (NNP DTI) (NN prediction) (NN problem)) (PP (IN by) (S (VP (VBG using) (NP (JJ topological) (NN information)) (ADVP (RB only))))))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (NN method)) (VP (VBN based) (PP (IN on) (NP (JJ low-rank) (NN matrix) (NN projection)))) (SBAR (S (VP (TO to) (VP (VB solve) (NP (DT the) (NNP DTI) (NN prediction) (NN problem)))))))) (. .))
(S (PP (IN On) (NP (CD one) (NN hand))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (JJ extra) (JJ characteristic) (NN information)) (PP (IN of) (NP (NNS drugs) (CC or) (NNS targets))))))) (, ,) (NP (DT the) (VBN proposed) (NN method)) (VP (VBZ utilizes) (NP (RB only) (DT the) (VBN known) (NNS interactions))) (. .))
(S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (S (NP (DT the) (VBN proposed) (NN method)) (VP (MD can) (ADVP (RB also)) (VP (VB utilize) (NP (DT the) (JJ extra) (JJ characteristic) (NN information)) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ available)))))))) (CC and) (S (NP (DT the) (NNS performances)) (VP (MD will) (VP (VB be) (ADJP (RB remarkably) (VBN improved))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (DT the) (VBN proposed) (NN method)) (VP (MD can) (VP (VB predict) (NP (NP (DT the) (NNS interactions)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ new) (NNS drugs) (CC or) (NNS targets)) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (PRP we)) (VP (VBP know) (NP (NP (NP (NN nothing)) (PP (IN about) (NP (PRP$ their) (JJ associated) (NNS interactions)))) (, ,) (CC but) (NP (RB only) (DT some) (JJ characteristic) (NN information)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP compare) (NP (DT the) (VBN proposed) (NN method)) (PP (IN with) (NP (NP (JJ ten) (NN baseline) (NNS methods)) (, ,) (NP (NN e.g.)) (, ,) (NP (NP (NP (CD six) (JJ similarity-based) (NNS methods)) (SBAR (WHNP (WDT that)) (S (VP (VBP utilize) (NP (RB only) (DT the) (VBN known) (NNS interactions)))))) (CC and) (NP (NP (CD four) (NNS methods)) (SBAR (WHNP (WDT that)) (S (VP (VBP utilize) (NP (DT the) (JJ extra) (JJ characteristic) (NN information)))))))))) (. .))
(S (NP (NP (DT The) (NNS datasets) (CC and) (NNS codes)) (VP (VBG implementing) (NP (DT the) (NNS simulations)))) (VP (VBP are) (ADJP (JJ available)) (PP (IN at) (NP (DT this) (NN https) (NNP URL)))))
